Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis
Conditions: Hepatocellular Carcinoma; Radiotherapy; Tislelizumab; Tumor Thrombosis Interventions: Radiation: Moderate-dose Hypofractionated Intensity-modulated Radiotherapy; Drug: Tislelizumab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Artificial Intelligence Support in Novice's Decision-making for Assessing Ultrasound Fetal Weight Estimation - A Randomized Trial
Conditions: Fetal Weight; Ultrasound Interventions: Behavioral: Artificial Intelligence feedback for ultrasound EFW standard plane images Sponsors: Copenhagen Academy for Medical Education and Simulation; Slagelse Hospital; Technical University of Denmark Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Conditions: Breast Cancer; Triple Negative Breast Cancer Interventions: Drug: Adebrelimab; Drug: Vinorelbine; Drug: Cyclophosphamide (tablet); Drug: Capecitabine Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Efficacy of an aloe vera, chamomile, and thyme cosmetic cream for the prophylaxis and treatment of mild dermatitis induced by radiation therapy in breast cancer patients: a controlled clinical trial (Alantel Trials)
The objective was to evaluate the effect of a cream (Alantel) based on natural products at high concentrations for the preventive and cura tive treatment (at early stages) of radiation-induced dermatitis in patients with breast cancer.MethodsOur protocol is an experimental, prospective, triple-blind, multicenter, controlled clinical trial with two parallel arms. The experimental group will be treated with Alantel, while the control group will receive another moisturizing cream. Radiotherapy oncology professionals will recruit a total of 88 patients (44 per comparison group) with breast cancer who will receive radiotherapy ...
Source: Trials - January 25, 2024 Category: Research Source Type: clinical trials
Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules
Conditions: Adenocarcinoma of Lung Interventions: Diagnostic Test: Mass spectrometry-based proteomics Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Wearable Devices System Diagnoses Mood Disorder in Children and Adolescents
Conditions: Mood Disorders; Diagnosis, Psychiatric Sponsors: Institute of Psychology, Chinese Academy of Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis
Conditions: Embolism and Thrombosis; Anticoagulation Interventions: Procedure: Extended anticoagulation Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Balloon Pulmonary Angioplasty vs. Combined Approach With Pulmonary Artery Denervation in CTEPH: Effectiveness Comparison
Conditions: Chronic Thromboembolic Pulmonary Hypertension Interventions: Procedure: Balloon Pulmonary Angioplasty combined with Pulmonary Artery Denervation; Procedure: Balloon Pulmonary Angioplasty with Sham Pulmonary Artery Denervation Sponsors: Boris Dzudovic; Military Medical Academy, Belgrade, Serbia; Galen Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
Conditions: Hand, Foot and Mouth Disease Interventions: Biological: Enterovirus Type 71 Vaccine, inactivated ( Human Diploid Cell ); Biological: Recombinant Hepatitis B Vaccine; Biological: Group A meningococcal polysaccharide vaccine Sponsors: Jiangsu Province Centers for Disease Control and Prevention; Institute of Medical Biology, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.
Conditions: Hypertension; Renal Denervation; Proteomics Interventions: Diagnostic Test: Urine sample for proteomic analysis; Diagnostic Test: ABPM; Diagnostic Test: OBPM Sponsors: Hippocration General Hospital; National and Kapodistrian University of Athens; Biomedical Research Foundation, Academy of Athens Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
Conditions: Hepatocellular Carcinoma; Narrow Margin; Radiotherapy Interventions: Radiation: Adjuvant SIB radiotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine
Conditions: PFO - Patent Foramen Ovale; Migraine; Migraine Headache; Migraine Headache, With or Without Aura Interventions: Device: Biodegradable occluder; Device: Metal occluder Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery
Conditions: Hepatocellular Carcinoma Interventions: Drug: RD-Cy7 fluorophore Sponsors: Institute of Automation, Chinese Academy of Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Phase II Study of Radiotherapy Plus Envolizumab and Capecitabine in Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer; Radiotherapy; Envolizumab; Capecitabine Interventions: Other: Radiotherapy Plus Envolizumab and Capecitabine Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
